Literature DB >> 20827773

Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: antibody profile of seroconverters and individuals with false reactions.

Marina Lobato Martins1, Ana Carolina da Silva Santos, Maria Sueli Namen-Lopes, Edel Figueiredo Barbosa-Stancioli, Denise Gonçalves Utsch, Anna Bárbara de F Carneiro-Proietti.   

Abstract

The high proportion of indeterminate results of the screening test for human T-lymphotropic virus (HTLV) infection has been a challenge worldwide. In this study, 60 persons with seroindeterminate results for HTLV were followed until their serological status was defined. At least two independent serological tests (EIA and WB) from sequential samples were performed at an average interval of 4.4 years, totaling 141 serum samples tested. Seroconversion occurred in 12 individuals (reactive by EIA, positive by WB and PCR), and 48 were classified as false reactions (non-reactive EIA and negative PCR, but indeterminate WB). The seroconverter group had epidemiological features similar to those seen in HTLV-1 carriers, and the average time of follow-up for seroconversion was 4 years. In the group with false reactions, the most frequent indeterminate WB pattern in the samples was the presence of p24 alone. This pattern was absent in the seroconverter group, suggesting that p24 alone is an indicator of false reactivity. In contrast, the presence of p19 and p24 seems to be an indicator of true reactivity, since this pattern was frequent (66.7%) among the seroconverters and much less common (10.4% of the first samples) among the individuals with false reactions (P = 0.0001). Thus, HTLV infection may be suspected when reactivity to p19 and p24 is observed. Individuals with an indeterminate WB pattern should be followed-up and retested. The improvement of the HTLV algorithm screening of blood donors has been necessary to reduce inconclusive results and to avoid unnecessary follow-up to define the status of infection. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827773     DOI: 10.1002/jmv.21881

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections.

Authors:  Gabriela de Melo Franco; Anderson Santos da Rocha; Laura Jorge Cox; Danielle Soares de Oliveira Daian E Silva; Débora Marques da Silveira E Santos; Marina Lobato Martins; Luis Claudio Romanelli; Ricardo Ishak; Antonio C R Vallinoto; Maria Rosa Q Bomfim; Adele Caterino-de-Araujo; Jordana G A Coelho-Dos-Reis; Flávio Guimarães da Fonseca; Edel Figueiredo Barbosa-Stancioli
Journal:  Front Public Health       Date:  2022-05-23

Review 4.  The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.

Authors:  Anna Abrams; Yoshimi Akahata; Steven Jacobson
Journal:  Viruses       Date:  2011-08-02       Impact factor: 5.048

5.  Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil.

Authors:  Karoline R Campos; Fred L N Santos; Bernardo Galvão-Castro; Adele Caterino-de-Araujo; Vanessa da Silva Brito; Noilson L S Gonçalves; Thessika H A Araujo
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

6.  Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey.

Authors:  Le Chang; Shanhai Ou; Zhengang Shan; Faming Zhu; Huimin Ji; Xia Rong; Fei Guo; Xinyi Jiang; Huizhen Sun; Ying Yan; Lunan Wang
Journal:  Retrovirology       Date:  2021-01-07       Impact factor: 4.602

7.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

8.  A New Flow Cytometry-Based Single Platform for Universal and Differential Serodiagnosis of HTLV-1/2 Infection.

Authors:  Luciene Pimenta de Paiva; Jordana Grazziela Alves Coelho-Dos-Reis; Bruno Caetano Trindade; Vanessa Peruhype-Magalhães; Márcio Sobreira Silva Araújo; Juan Jonathan Gonçalves; Ana Caroline Nogueira; Júlia Pereira Martins; Ágata Lopes Ribeiro; Ana Lucia Starling; Luiz Carlos Júnior Alcântara; Maísa Aparecida Ribeiro; Anna Bárbara de Freitas Carneiro-Proietti; Ester Cerdeira Sabino; Kelly Alves Bicalho; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

9.  Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Accurate Confirmatory Diagnosis of HTLV-1/2 Infection.

Authors:  Yago Gomes; Adele Caterino-de-Araujo; Karoline Campos; Maria Gisele Gonçalves; Ana Claudia Leite; Marco Antonio Lima; Abelardo Araújo; Marcus Tulius Silva; Otávio Espíndola
Journal:  Viruses       Date:  2020-09-04       Impact factor: 5.048

10.  A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections.

Authors:  Lola Marqué; Peter Liehl; Jasper De Boer; Hans Pottel; Edward L Murphy; Roberta Bruhn; Mars Stone; Zhanna Kaidarova; Tzong-Hae Lee; Michael Busch; Maan Zrein
Journal:  PLoS Negl Trop Dis       Date:  2021-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.